Pregnancy Exposures and Outcomes in Women with Inflammatory Bowel Disease Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States First published 06/08/2024 Last updated 18/08/2025 EU PAS number:EUPAS1000000283 Study Ongoing